Cellectar Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $330 | $330 |
Gross Profit | -66 | 260 | 260 | |
EBITDA | -13,259 | -12,477 | -12,477 | |
EBIT | -13,327 | -12,547 | -12,547 | |
Net Income | -14,664 | -919 | -7,448 | -7,448 |
Net Change In Cash | 0 | 0 | 330 | 330 |
Free Cash Flow | -9,166 | -14,162 | -9,862 | -9,862 |
Cash | 34,263 | 25,868 | 9,564 | 9,564 |
Basic Shares | 39,794 | 35,848 | 18,609 | 18,609 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -192 | -238 | -227 |
EBITDA | -38,768 | -28,665 | -23,981 |
EBIT | -38,960 | -28,813 | -24,131 |
Net Income | -37,983 | -28,601 | -23,970 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -33,241 | -25,448 | -22,710 |
Cash | 9,564 | 19,866 | 35,703 |
Basic Shares | 12,221 | 7,055 | 5,551 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.37 |
2024-06-30 | -$0.03 |
2024-03-31 | -$0.74 |
2023-12-31 | -$0.61 |
